Amundi Biogen Inc. Transaction History

Amundi

$295 Billion
Q3 2025

A detailed history of Amundi transactions in Biogen Inc. stock. As of the latest transaction made, Amundi holds 618,309 shares of BIIB stock, worth $104 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

618,309

Previous 579,797 6.64%

Holding current value

$104 Million

Previous $72.8 Million 18.95%

% of portfolio

0.03%

Previous 0.03%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$122.68 - $148.84 $4.72 Million - $5.73 Million	38,512 Added 6.64%	618,309 $86.6 Million
Q2 2025 Aug 13, 2025	SELL	$113.38 - $135.49 $83.5 Million - $99.7 Million	-736,150 Reduced 55.94%	579,797 $72.8 Million
Q1 2025 May 15, 2025	BUY	$133.43 - $153.27 $13.2 Million - $15.2 Million	98,957 Added 8.13%	1,315,947 $180 Million
Q4 2024 Feb 07, 2025	BUY	$146.47 - $191.55 $46.8 Million - $61.2 Million	319,478 Added 35.6%	1,216,990 $186 Million
Q3 2024 Nov 13, 2024	BUY	$189.07 - $236.8 $40.2 Million - $50.4 Million	212,692 Added 31.06%	897,512 $174 Million

Q2 2024 Aug 14, 2024	SELL	$190.52 - $236.72 $57.3 Million - $71.2 Million	-300,982 Reduced 30.53%	684,820 $159 Million
Q1 2024 May 15, 2024	SELL	$212.02 - $267.71 $45.8 Million - $57.8 Million	-215,904 Reduced 17.97%	985,802 $213 Million
Q4 2023 Feb 14, 2024	BUY	$222.59 - $267.94 $24.1 Million - $29 Million	108,182 Added 9.89%	1,201,706 $311 Million
Q3 2023 Nov 14, 2023	SELL	$253.3 - $285.89 $23.8 Million - $26.8 Million	-93,789 Reduced 7.9%	1,093,524 $281 Million
Q2 2023 Aug 14, 2023	BUY	$275.25 - $318.06 $168 Million - $194 Million	609,020 Added 105.31%	1,187,313 $338 Million
Q1 2023 May 15, 2023	SELL	$256.56 - $292.34 $61.7 Million - $70.3 Million	-240,340 Reduced 29.36%	578,293 $161 Million
Q4 2022 Feb 14, 2023	BUY	$252.44 - $306.72 $42.8 Million - $52.1 Million	169,737 Added 26.16%	818,633 $227 Million
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $46.9 Million - $64.7 Million	241,061 Added 59.11%	648,896 $170 Million
Q2 2022 Aug 15, 2022	BUY	$187.54 - $223.02 $11.4 Million - $13.5 Million	60,579 Added 17.45%	407,835 $87.4 Million
Q1 2022 May 16, 2022	SELL	$193.77 - $244.14 $88.4 Million - $111 Million	-456,338 Reduced 56.79%	347,256 $73.5 Million
Q4 2021 Feb 14, 2022	SELL	$223.92 - $287.77 $11.5 Million - $14.8 Million	-51,409 Reduced 6.01%	803,594 $190 Million
Q3 2021 Nov 15, 2021	BUY	$282.99 - $369.05 $66.6 Million - $86.8 Million	235,305 Added 37.97%	855,003 $242 Million
Q2 2021 Aug 16, 2021	BUY	$259.0 - $414.71 $161 Million - $257 Million	619,698 New	619,698 $215 Million

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $24.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amundi, based on Form 13F filings with the SEC.

News

Stay updated on Amundi with notifications on news.

Account